EDN1 and heart failure: An increase in ET-1 production characterizes thepathological conditions of hypertrophic heart disease and heart failure.Prolonged administration of antagonists of the ET-A-type receptor is efficaciousin ameliorating modifications in cardiac gene expression resulting from thesepathological processes [45].